surmount tirzepatide trials ECO 2026: SURMOUNT-MAINTAIN proves sustains weight loss long term SURMOUNT-2: Tirzepatide confers about 15%
Description
The mechanisms
Clinical data shows tirzepatide produces approximately 35% greater weight loss than semaglutide at comparable treatment durations, achieved through superior receptor coverage rather than medication multiplication
Reference: Busetto L, et al
doi: 10.1042/cs0830367 36 HauserW
And it could fundamentally change how weight loss medications are delivered
